Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (771-780 of 1,115) with videos related to

Pageof 112
Sort By:
Cancer|July 16, 2008
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemiaApostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, et al.
Blood|December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivoSabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.
Cancer Treatment Reports|June 1, 1979
Phase I-II study of piperazinedione in adults with solid tumors and acute leukemiaR S Benjamin, M J Keating, M Valdivieso, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejectionAbraham Shaked, Bao-Li Chang, Michael R Barnes, et al.
Cancer|March 7, 2017
Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal modelJane J Keating, Jeffrey J Runge, Sunil Singhal, et al.
Cancer|December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patientsS Sacchi, H M Kantarjian, S O'Brien, et al.
Bioorganic & Medicinal Chemistry|January 14, 2011
Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agentsYvonne M McNamara, Suzanne M Cloonan, Andrew J S Knox, et al.
Immunogenetics|November 12, 2005
Extensive genomic and functional polymorphism of the complement control proteinsCraig A McLure, Joseph F Williamson, Louise A Smyth, et al.
Cancer|May 12, 2006
Activity of alemtuzumab in patients with CD52-positive acute leukemiaRaoul Tibes, Michael J Keating, Alessandra Ferrajoli, et al.
The Journal of Physiology|October 9, 2013
Identification of unique release kinetics of serotonin from guinea-pig and human enterochromaffin cellsRavinarayan Raghupathi, Michael D Duffield, Leah Zelkas, et al.
Pageof 112

Showing results (771-780 of 1,115) with videos related to

Sort By:
Pageof 112
Cancer|July 16, 2008
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemiaApostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, et al.
Blood|December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivoSabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.
Cancer Treatment Reports|June 1, 1979
Phase I-II study of piperazinedione in adults with solid tumors and acute leukemiaR S Benjamin, M J Keating, M Valdivieso, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejectionAbraham Shaked, Bao-Li Chang, Michael R Barnes, et al.
Cancer|March 7, 2017
Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal modelJane J Keating, Jeffrey J Runge, Sunil Singhal, et al.
Cancer|December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patientsS Sacchi, H M Kantarjian, S O'Brien, et al.
Bioorganic & Medicinal Chemistry|January 14, 2011
Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agentsYvonne M McNamara, Suzanne M Cloonan, Andrew J S Knox, et al.
Immunogenetics|November 12, 2005
Extensive genomic and functional polymorphism of the complement control proteinsCraig A McLure, Joseph F Williamson, Louise A Smyth, et al.
Cancer|May 12, 2006
Activity of alemtuzumab in patients with CD52-positive acute leukemiaRaoul Tibes, Michael J Keating, Alessandra Ferrajoli, et al.
The Journal of Physiology|October 9, 2013
Identification of unique release kinetics of serotonin from guinea-pig and human enterochromaffin cellsRavinarayan Raghupathi, Michael D Duffield, Leah Zelkas, et al.
Pageof 112